TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

42.50$ +0.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow LBRX
Line item 2022 2023 2024 2025
+100.0% +2,175.0% +252.7%
-31.6% +971.5% +32.6%
-1,626.7% -512.0%
+2,976.0% -93.2%
-22,872.4% -271.7%
-97.1% -100.0%
+46.7% +13.8% +689.7%
-131.6% +2,573.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?